Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CALCA | P06881 | 2/20 | 0.50 |
| ▸ | CAPN1 | P07384 | 2/20 | 0.50 |
| ▸ | CTSB | P07858 | 2/20 | 0.50 |
| ▸ | IL23R | Q5VWK5 | 1/20 | 0.49 |
| ▸ | GRPR | P30550 | 4/20 | 0.49 |
| ▸ | GLP1R | P43220 | 6/20 | 0.48 |
| ▸ | GIPR | P48546 | 6/20 | 0.48 |
| ▸ | NMBR | P28336 | 2/20 | 0.48 |
| ▸ | NPY1R | P25929 | 1/20 | 0.47 |
| ▸ | NPY2R | P49146 | 1/20 | 0.47 |
| ▸ | NPY4R | P50391 | 1/20 | 0.47 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.47 |
| ▸ | KISS1R | Q969F8 | 2/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31670611 | 0.87 | IL23R (0.57) | CALCAIL23RGRPRGLP1RGIPR | |
| SCHEMBL31670646 | 0.84 | DPP3 (0.54) | CALCACAPN1CTSBIL23RKISS1R | |
| SCHEMBL31058453 | 0.84 | GLP1R (0.55) | GLP1RGIPR | |
| SCHEMBL31058456 | 0.84 | C5AR1 (0.56) | GLP1RGIPR | |
| SCHEMBL30666394 | 0.83 | CXCR4 (0.63) | CALCAGLP1RNPY1RNPY2RNPY4R | |
| SCHEMBL30608612 | 0.83 | GLP1R (0.52) | CAPN1CTSBGRPRGLP1RGIPR | |
| SCHEMBL30906530 | 0.82 | CALCA (0.54) | CALCAGLP1RGIPRNPY1RNPY2R | |
| SCHEMBL30608584 | 0.82 | GLP1R (0.55) | CAPN1CTSBGLP1RGIPRNPY1R | |
| SCHEMBL30608594 | 0.82 | CAPN1 (0.54) | CAPN1CTSBGRPRGLP1RGIPR | |
| SCHEMBL31019423 | 0.82 | CAPN1 (0.53) | CAPN1CTSBGRPR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220170933-A1 | METHOD FOR DIAGNOSING AND STAGING HERPESVIRUS-MEDIATED NEURODEGENERATION | CUTLER RICHELLE GAYLE (US) | 2022-06-02 | — | — | US | claimed |
| US-20240173375-A1 | CHEMOTACTIC AUTOPHAGY-INHIBITING PEPTIDE, COMPOSITIONS AND METHODS RELATED THERETO | BIOTEMPT B.V. (NL) | 2024-05-30 | — | — | US | disclosed |
| EP-4301391-A1 | CHEMOTACTIC AUTOPHAGY-INHIBITING PEPTIDE, COMPOSITIONS AND METHODS RELATED THERETO | Biotempt B.V. (NL) | 2024-01-10 | — | — | EP | disclosed |
| WO-2022186690-A1 | CHEMOTACTIC AUTOPHAGY-INHIBITING PEPTIDE, COMPOSITIONS AND METHODS RELATED THERETO. | BIOTEMPT B.V. (NL) | 2022-09-09 | — | — | WO | disclosed |
| US-20220170933-A1 | METHOD FOR DIAGNOSING AND STAGING HERPESVIRUS-MEDIATED NEURODEGENERATION | CUTLER RICHELLE GAYLE (US) | 2022-06-02 | — | — | US | disclosed |